Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Non Operating Income (2016 - 2025)

Abeona Therapeutics (ABEO) has 12 years of Non Operating Income data on record, last reported at $129000.0 in Q3 2025.

  • For Q3 2025, Non Operating Income fell 11.03% year-over-year to $129000.0; the TTM value through Sep 2025 reached $1.0 million, up 37.18%, while the annual FY2024 figure was $1.2 million, 59.43% down from the prior year.
  • Non Operating Income reached $129000.0 in Q3 2025 per ABEO's latest filing, up from $89000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.2 million in Q2 2023 and bottomed at -$118000.0 in Q2 2022.
  • Average Non Operating Income over 4 years is $335307.7, with a median of $145000.0 recorded in 2024.
  • Peak YoY movement for Non Operating Income: surged 1977.12% in 2023, then tumbled 89.89% in 2024.
  • A 4-year view of Non Operating Income shows it stood at -$19000.0 in 2022, then surged by 1226.32% to $214000.0 in 2023, then soared by 209.81% to $663000.0 in 2024, then tumbled by 80.54% to $129000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $129000.0 in Q3 2025, $89000.0 in Q2 2025, and $141000.0 in Q1 2025.